Target intelligence / Profile preview

Adipokine signaling pathway

01

Overview

Adipokine signaling pathway (also called adipocytokine signaling pathway) refers to a complex network of signaling events initiated by adipokines—hormonal and cytokine-like molecules secreted by adipose tissue[1][3][6][9]. These pathways centrally regulate energy homeostasis, lipid metabolism, insulin sensitivity, inflammation, and immune function[3][4][6]. Key adipokines include adiponectin, leptin, resistin, and others. The pathway involves multiple signal mediators, such as AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptors (PPARs), Janus kinases/signal transducers and activators of transcription (JAK/STAT), PI3K/Akt, and others[1][2][6][7]. Disruption or dysregulation of adipokine signaling is linked to obesity, type 2 diabetes, metabolic syndrome, cardiovascular diseases, osteoarthritis, and autoimmune conditions[6][7][8]. However, the adipokine signaling pathway is not a single molecular target, receptor, or protein; it encompasses many different cellular components, ligands, receptors (such as AdipoR1, AdipoR2 for adiponectin; leptin receptor for leptin), and downstream molecules[2][3][6]. As such, it is not referred to as a therapeutic target in the sense of a single molecule (receptor, enzyme, transporter) suitable for direct drug targeting; instead, individual pathway components (e.g., adiponectin receptor 1, leptin receptor) may be considered targets[2][5]. It would be necessary to specify a particular component within this pathway (such as “adiponectin receptor 1” or “leptin receptor”) to meet the criteria for a canonical therapeutic target. There are no official abbreviations, molecular classifications, drug lists, or biomarker details that can be assigned to the “adipokine signaling pathway” as a whole. For structured data, focus on individual pathway members (e.g., AdipoR1, AdipoR2, leptin receptor) rather than the pathway aggregate. Correction: - "Adipokine signaling pathway" is not a specific target molecule, protein, or receptor but a pathway comprising many such individual entities. - For curation or database purposes, this entry should be flagged as non-compliant with requirements for a target entry. A more appropriate target would be, for example, “Adiponectin receptor 1 (AdipoR1)” or “Leptin receptor.”

Other names
Adipocytokine signaling pathwayAdipokine signaling
02

Biological functions

regulate energy homeostasislipid metabolisminsulin sensitivityinflammationimmune function
03

Disease associations

obesitytype 2 diabetesmetabolic syndromecardiovascular diseasesosteoarthritisautoimmune conditions

Beyond the preview

Go deeper on Adipokine signaling pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipokine signaling pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call